Dr. Steven Victor CEO Announces ReGen BioSciences will Open Adipose Stem Cell Processing Centers in Dallas/Fort Worth and Philadelphia

Share Article

ReGen BioSciences's CEO Dr. Steven Victor announces that it has signed a deal to open up Adipose Stem Cell Processing Centers in Dallas/Ft Worth and Philadelphia in the next 6 weeks. These centers will make adipose stem cellls available for doctors in the surrounding area. The cell will also be banked for future use. The medical field of autologous adipose stem cells is a new and exciting frontier in medicine. Physicians and researchers are looking into using this stem cells for aesthetics, orthopedics and wound healing.

ReGen is setting the gold standard for adipose stem cell processing with stem cell counts and viability checks for each specimen it processes which can document the quality and quantity of the stem cells.

Dr. Steven Victor CEO of ReGen BioSciences, a company operating and marketing upscale Rejuvenation Centers that provides stem cell rejuvenation, adipose stem cell separation and aesthetic treatments, announces he has signed Agreements to open Adipose Stem Cell processing Centers in Dallas/Fort Worth and Philadelphia in the next 6 weeks. These centers will be able to accept fat from doctors’ patients within a 50 mile radius of each center. Return of the adipose stem cells to the doctor could be as quickly as the same day. ReGen will also have the capacity to bank additional stem cells for future applications.

The use of autologous adipose (fat) stem cells has become a new and exciting frontier in medicine. Numerous doctors, companies and researchers are studying the use of these adipose stem cells for enriching fat for breast, buttock and face augmentation. Additional applications of the technology include the treatment of arthritis and numerous orthopedic injuries such as knees, elbows and shoulders; wound healing; congestive heart failure, gum regeneration and other diseases.

In the aesthetic world the use of autolgous adipose stem cells has become widely accepted in Europe and Asia. Since the middle of 2009 when the US FDA published its laws on autologous stem cells the field has expanded rapidly.

ReGen BioSciences has developed an in-house technology where it can easily process adipose stem cell with high counts and excellent viability. At present it is the only company that actually counts and checks the adipose stem cells. According to Dr. Steven Victor CEO " ReGen is setting the gold standard for adipose stem cell processing with stem cell counts and viability checks for each specimen it processes which can document the quality and quantity of the stem cells.”

The adipose stem cell processing technique of ReGen BioSciences takes approximately one hour and the stem cells can be returned to the doctor in the same day. Also the adipose stem cells can be sent to the ReGen Banking facility for storage for future use. Autologous Adipose Stem Cells are on the cutting edge of medicine and ReGen BioSciences is excited to be one of the premier companies to participate in this field.

About ReGen BioSciences:

ReGen BioSciences Inc. is a company founded on two converging and symbiotic trends. The first trend is one of the most exciting frontiers in medicine which are the possibilities concerning the clinical utility of adult (as opposed to embryonic) adipose (fat) stem cells.

Theoretically, adult adipose stem cells have the potential to restore beauty, heal damaged tissues, and to treat and possibly improve some diseases. (http://www.VetStem.com, http://www.Cytori.com, Reference Exhibit) Recently, new techniques have been discovered that enable stem cells to be extracted from your own fat tissue, also known as adipose tissue. On April 1, 2009 the FDA issued a ruling (Title 21, Chapter I, Subchapter L, Part 1271, Sec 1271.10) which effectively allowed for the autologous (returning one’s own cells to the same person from which they were extracted) use of stem cells, so long as they are only minimally manipulated. ReGen BioSciences plans to be the first company to offer the physician’s office the expertise to withdraw autologous, adipose derived stem cells.

For more information email RSexauer(at)ReGenBioSciences(dot)com
212-249-3050

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Steven Victor MD
ReGen BioSciences
212 249 3050
Email >